QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NASDAQ:NBIX

Neurocrine Biosciences - NBIX Insider Trading & Ownership

$97.21
+2.96 (+3.14%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$93.55
▼
$97.49
50-Day Range
$94.11
▼
$111.36
52-Week Range
$75.25
▼
$129.29
Volume
678,259 shs
Average Volume
860,981 shs
Market Capitalization
$9.39 billion
P/E Ratio
63.54
Dividend Yield
N/A
Price Target
$125.65

Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$39.03 M
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$29.12 M

NBIX Insider Buying and Selling by Quarter

Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Neurocrine Biosciences Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.448,575,316  
2/8/2023Eric BenevichInsiderSell980$104.12$102,037.6034,381  
2/8/2023Kevin Charles GormanCEOSell2,274$104.30$237,178.20491,365  
2/7/2023Matt AbernethyCFOSell26,328$102.40$2,695,987.2024,333  
2/6/2023Eric BenevichInsiderSell1,280$105.63$135,206.4017,879  
2/6/2023Kevin Charles GormanCEOSell3,040$105.68$321,267.20468,008  
1/31/2023Eiry RobertsInsiderSell1,457$109.99$160,255.4326,171  
1/31/2023Kevin Charles GormanCEOSell2,707$110.08$297,986.56465,278  
1/31/2023Matt AbernethyCFOSell1,283$109.98$141,104.3421,357  
1/6/2023Eric BenevichInsiderSell400$125.00$50,000.0015,643  
1/3/2023Stephen A SherwinDirectorSell30,000$118.86$3,565,800.0025,055  
11/30/2022Eric BenevichInsiderSell50,000$125.90$6,295,000.0015,643  
11/10/2022Eric BenevichInsiderSell100$125.36$12,536.0015,643  
11/8/2022Eric BenevichInsiderSell24,593$125.33$3,082,240.6915,643  
11/3/2022Darin LippoldtInsiderSell4,518$125.02$564,840.3629,234  
11/1/2022Darin LippoldtInsiderSell10,000$120.09$1,200,900.0029,234  
10/31/2022Gary A LyonsDirectorSell15,000$114.76$1,721,400.00203,697  
10/27/2022Darin LippoldtInsiderSell4,923$115.04$566,341.9229,234  
10/17/2022Eric BenevichInsiderSell4,960$110.82$549,667.2015,643  
10/4/2022Gary A LyonsDirectorSell5,000$110.54$552,700.00203,697  
10/3/2022David W BoyerInsiderSell1,437$106.59$153,169.834,214  
8/12/2022Malcolm Lloyd-SmithInsiderSell21,533$105.95$2,281,421.3518,888  
6/27/2022Julie CookeInsiderSell754$100.00$75,400.0016,918  
5/9/2022Richard F PopsDirectorSell15,000$76.30$1,144,500.0029,512  
4/25/2022Gary A LyonsDirectorSell15,000$92.76$1,391,400.00208,697  
4/1/2022William H RastetterDirectorSell10,728$94.93$1,018,409.0434,022  
3/22/2022Darin LippoldtInsiderSell8,455$95.05$803,647.75  
(Data available from 1/1/2013 forward)












NBIX Insider Trading Activity - Frequently Asked Questions

Who is on Neurocrine Biosciences's Insider Roster?

The list of insiders at Neurocrine Biosciences includes Darin Lippoldt, David W Boyer, Dimitri E Grigoriadis, Eiry Roberts, Eric Benevich, Gary A Lyons, Haig P Bozigian, Julie Cooke, Kevin Charles Gorman, Kyle Gano, Malcolm Lloyd-Smith, Matt Abernethy, Neurocrine Biosciences Inc, Richard F Pops, Stephen A Sherwin, and William H Rastetter. Learn more on insiders at NBIX.

What percentage of Neurocrine Biosciences stock is owned by insiders?

4.40% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings.

Which Neurocrine Biosciences insiders have been buying company stock?

The following insider purchased NBIX shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44).

How much insider buying is happening at Neurocrine Biosciences?

Insiders have purchased a total of 4,395,588 NBIX shares in the last 24 months for a total of $39,032,821.44 bought.

Which Neurocrine Biosciences insiders have been selling company stock?

The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($3,164,230.03), David W Boyer ($172,626.63), Dimitri E Grigoriadis ($838,480.00), Eiry Roberts ($356,339.43), Eric Benevich ($10,731,069.25), Gary A Lyons ($5,193,500.00), Julie Cooke ($175,807.51), Kevin Charles Gorman ($1,560,374.16), Kyle Gano ($2,416,743.00), Malcolm Lloyd-Smith ($3,848,725.55), Matt Abernethy ($3,240,366.99), Richard F Pops ($1,144,500.00), Stephen A Sherwin ($4,682,250.00), and William H Rastetter ($1,018,409.04).

How much insider selling is happening at Neurocrine Biosciences?

Insiders have sold a total of 368,177 Neurocrine Biosciences shares in the last 24 months for a total of $38,543,421.59 sold.

This page (NASDAQ:NBIX) was last updated on 3/20/2023 by MarketBeat.com Staff